Current Assets
Other current assets
Neurocrine Biosciences Other current assets decreased by 46.0% to $62.50M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 47.6%, from $119.30M to $62.50M. Over 5 years (FY 2020 to FY 2025), Other current assets shows an upward trend with a 30.9% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryLiquidity
SignalContext dependent
VolatilityStable
First reportedQ4 2014
Last reportedQ1 2026May 5, 2026
How to read this metric
Large, unexpected increases may warrant investigation into potential accounting adjustments or non-recurring items.
Detailed definition
This is a catch-all category for current assets that do not fit into standard classifications like cash, receivables, or...
Peer comparison
Standard across all industries; usually a minor component of the balance sheet.
Metric ID:
current_assets_other_assets_currentHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $38.40M | $50.50M | $45.50M | $60.80M | $62.70M | $67.90M | $79.10M | $113.20M | $100.60M | $108.20M | $97.80M | $100.50M | $120.20M | $121.70M | $63.60M | $119.30M | $120.70M | $68.20M | $115.80M | $62.50M |
| QoQ Change | — | +31.5% | -9.9% | +33.6% | +3.1% | +8.3% | +16.5% | +43.1% | -11.1% | +7.6% | -9.6% | +2.8% | +19.6% | +1.2% | -47.7% | +87.6% | +1.2% | -43.5% | +69.8% | -46.0% |
| YoY Change | — | — | — | — | +63.3% | +34.5% | +73.8% | +86.2% | +60.4% | +59.4% | +23.6% | -11.2% | +19.5% | +12.5% | -35.0% | +18.7% | +0.4% | -44.0% | +82.1% | -47.6% |
Range$38.40M – $121.70M
CAGR+10.8%
Avg YoY Growth+24.8%
Median YoY Growth+21.6%
Other current assets at Other Companies
Frequently Asked Questions
- What is Neurocrine Biosciences's other current assets?
- Neurocrine Biosciences (NBIX) reported other current assets of $62.50M in Q1 2026.
- How has Neurocrine Biosciences's other current assets changed year-over-year?
- Neurocrine Biosciences's other current assets decreased by 47.6% year-over-year, from $119.30M to $62.50M.
- What is the long-term trend for Neurocrine Biosciences's other current assets?
- Over 5 years (2020 to 2025), Neurocrine Biosciences's other current assets has grown at a 30.9% compound annual growth rate (CAGR), from $30.10M to $115.80M.
- What does other current assets mean?
- Miscellaneous current assets that do not fall into standard categories like cash or inventory.